DeutschNewstral
Article
Bbarrons.com on 2020-01-30 15:43
Biogen Stock Gets a Lift From Strong Earnings Report
Related news
- BBiogen Stock Is Falling Because Earnings Guidance Came Up Shortbarrons.com
- BBiogen Sold $1.6M of Aduhelm in Weeks After Approval. Earnings Were Strong.2 min readbarrons.com
- BBiogen Stock Is Soaring as Hope Returns for Alzheimer’s Drugbarrons.com
- BBiogen Reports Earnings This Week. Here’s What To Expect.barrons.com
- BBiogen Stock Jumps on FDA Approvalbarrons.com
- BBiogen Reports Earnings Tomorrow. Here’s What to Expect.barrons.com
- BCardinal Health Stock Climbs on Strong Earningsbarrons.com
- BHumana Stock Leaps on Strong Earnings Newsbarrons.com
- BBoston Scientific Stock Gains on Strong Earningsbarrons.com
Biogen earnings lift shares, but concerns about multiple sclerosis drug sales persistbizjournals.com- BBiogen Earnings Were Good, but an Alzheimer’s Drug Delay Hits Sharesbarrons.com
- BBiogen Beats Earnings Expectations but Leaves a Mystery on CFObarrons.com
- BSangamo Stock Is Soaring on Plan to Collaborate With Biogenbarrons.com
- IBiogen tops Q2 2022 earnings and revenue estimatesinvezz.com
- BBiogen Stock Slips as Multiple Sclerosis Drug Has Fierce Competitionbarrons.com
- BHow Biogen Stock Could Rise 85%. Two Drugs Are Critical.barrons.com
- BStrong Earnings, Forecast Lift P&G Stockbarrons.com
- BBiogen Announced a Big Stock Buyback. It May Not Be a Great Use of Cash.barrons.com
- BBiogen Drug Gets a Thumbs Down From Neurologistbarrons.com
- BBiogen Patent Ruling Won’t be a Stock Catalyst, Analyst Saysbarrons.com